Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P42345 (
mTOR
)
26,049
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Autophagy is closely related to the formation and development of multiple human tumors including ovarian cancer. As a major regulator of this process, the role of
mTOR
(
mammalian target of rapamycin
) has been well proven. Cardamonin, a kind of flavonoid from plants, has effects on induction of autophagy and thus antiproliferation of cancer cells. However, the detailed mechanism remains unclear.
DAP1
(death-associated protein 1) is a proline-rich protein, which is involved in the regulation of cellular growth and programmed cell death including autophagy and apoptosis. The aim of this study was to investigate whether
DAP1
is involved in proliferation inhibition and autophagy induced by cardamonin in tumor cells. Using online bioinformatics tools, we found that
DAP1
expression is closely related to the survival of patients with ovarian cancer. Our study showed that autophagy induced by cardamonin was associated with
mTOR
inhibition, and
DAP1
was involved in this process. Silence of
DAP1
decreased cell proliferation but enhanced the antiproliferative effect of cardamonin in SKOV3 cells. The level of autophagy was elevated by
DAP1
silencing in SKOV3 cells. Notably, cardamonin showed higher autophagy flux in the
DAP1
small interfering RNA group. Taken together, our results implied that
DAP1
negatively regulates autophagy induced by cardamonin, and it may be a potential target for ovarian cancer therapy.
...
PMID:DAP1 negatively regulates autophagy induced by cardamonin in SKOV3 cells. 3270 48